ZIPTUSS 3 MG/ML XPE CT FR PLAS AMB X 120 ML + COP
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1057307080063 -
GGREM
552920030121717 -
Código de barras
7896181922360
O que a fonte publica
- Detentor do registro
- ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
- Princípios ativos
- DROPROPIZINA
- Embalagem
- 3 MG/ML XPE CT FR PLAS AMB X 120 ML + COP
- Regime de dispensação
- Tarja Sem Tarja
- Tipo de produto
- Similar
- Classe terapêutica
- R5D1 - ANTITUSSÍGENOS PUROS
- Prescrição
- Isento de prescrição
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "ZIPTUSS 3 MG/ML XPE CT FR PLAS AMB X 120 ML + COP",
"holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
"stripe": "Tarja Sem Tarja",
"barcodes": [
"7896181922360"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "552920030121717",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.659.463/0029-92",
"priceRegime": "Regulado",
"productName": "ZIPTUSS",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "3 MG/ML XPE CT FR PLAS AMB X 120 ML + COP",
"sourceStatus": null,
"supplyRegime": "Tarja Sem Tarja",
"factoryPrices": {
"icms-0": "16.90",
"icms-12": "19.20",
"icms-17": "20.36",
"icms-18": "20.61",
"icms-19": "20.86",
"icms-20": "21.13",
"icms-21": "21.39",
"icms-22": "21.67",
"icms-23": "21.95",
"icms-17.5": "20.48",
"icms-19.5": "20.99",
"icms-20.5": "21.26",
"icms-22.5": "21.81",
"icms-12-alc": "17.15",
"icms-17-alc": "18.18",
"icms-18-alc": "18.40",
"icms-19-alc": "18.63",
"icms-20-alc": "18.86",
"icms-21-alc": "19.10",
"icms-22-alc": "19.35",
"icms-23-alc": "19.60",
"withoutTaxes": "15.09",
"icms-17.5-alc": "18.29",
"icms-19.5-alc": "18.74",
"icms-20.5-alc": "18.98",
"icms-22.5-alc": "19.47"
},
"pisCofinsList": "Negativa",
"substanceText": "DROPROPIZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "22.67",
"icms-12": "25.76",
"icms-17": "27.31",
"icms-18": "27.65",
"icms-19": "27.98",
"icms-20": "28.35",
"icms-21": "28.69",
"icms-22": "29.07",
"icms-23": "29.45",
"icms-17.5": "27.47",
"icms-19.5": "28.16",
"icms-20.5": "28.52",
"icms-22.5": "29.26",
"icms-12-alc": "23.71",
"icms-17-alc": "25.13",
"icms-18-alc": "25.44",
"icms-19-alc": "25.75",
"icms-20-alc": "26.07",
"icms-21-alc": "26.40",
"icms-22-alc": "26.75",
"icms-23-alc": "27.10",
"withoutTaxes": "20.86",
"icms-17.5-alc": "25.28",
"icms-19.5-alc": "25.91",
"icms-20.5-alc": "26.24",
"icms-22.5-alc": "26.92"
},
"invalidBarcodes": [],
"activeSubstances": [
"DROPROPIZINA"
],
"therapeuticClass": "R5D1 - ANTITUSSÍGENOS PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1057307080063",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "non-prescription",
"prescriptionRequired": false,
"therapeuticClassCode": "R5D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:552920030121717"